Bridgeway Capital Management’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-79,500
Closed -$55.4K 1437
2023
Q3
$55.4K Hold
79,500
﹤0.01% 1291
2023
Q2
$70.6K Hold
79,500
﹤0.01% 1302
2023
Q1
$59.9K Hold
79,500
﹤0.01% 1294
2022
Q4
$91.4K Hold
79,500
﹤0.01% 1231
2022
Q3
$70K Buy
+79,500
New +$96.2K ﹤0.01% 1325
2022
Q2
Sell
-100,000
Closed -$139K 1395
2022
Q1
$139K Sell
100,000
-73,300
-42% -$157K ﹤0.01% 1229
2021
Q4
$591K Buy
+173,300
New +$976K 0.01% 931

Other funds holding AFIB

Bridgeway Capital Management's AFIB Position: Q4 2023 in Review

Bridgeway Capital Management sold out of Acutus Medical Inc (AFIB) in Q4 2023, closing a stake of 79,500 shares — an estimated $55.4K sold.

Bridgeway Capital Management first reported a position in AFIB in Q4 2021 and held it in 7 quarters. The position peaked at $591K in Q4 2021. 29 funds tracked by Wall St. Rank hold AFIB as of Q4 2023.

  • Bridgeway Capital Management reported no remaining Acutus Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 79,500 Acutus Medical Inc shares in Q4 2023, an estimated $55.4K.
  • Bridgeway Capital Management first reported a position in Acutus Medical Inc in Q4 2021 and held it in 7 quarters.
  • Bridgeway Capital Management's Acutus Medical Inc position peaked at $591K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.